These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8371897)

  • 1. Increased lung uptake of 99Tcm-sulphur colloid as an early indicator of the development of hepatic veno-occlusive disease in bone marrow transplant patients.
    Jacobson AF; Teefey SA; Higano CA; Bianco JA
    Nucl Med Commun; 1993 Aug; 14(8):706-11. PubMed ID: 8371897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lung uptake on technetium-99m-sulfur colloid liver-spleen scans in patients with hepatic venoocclusive disease following bone marrow transplantation.
    Jacobson AF; Marks MA; Kaplan WD
    J Nucl Med; 1990 Mar; 31(3):372-4. PubMed ID: 2308010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
    Carreras E; Bertz H; Arcese W; Vernant JP; Tomás JF; Hagglund H; Bandini G; Esperou H; Russell J; de la Rubia J; Di Girolamo G; Demuynck H; Hartmann O; Clausen J; Ruutu T; Leblond V; Iriondo A; Bosi A; Ben-Bassat I; Koza V; Gratwohl A; Apperley JF
    Blood; 1998 Nov; 92(10):3599-604. PubMed ID: 9808553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
    Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
    Litzow MR; Repoussis PD; Schroeder G; Schembri-Wismayer D; Batts KP; Anderson PM; Arndt CA; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Noël P; Solberg LA; Letendre L; Hoagland HC
    Leuk Lymphoma; 2002 Nov; 43(11):2099-107. PubMed ID: 12533034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
    Blostein MD; Paltiel OB; Thibault A; Rybka WB
    Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
    Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
    Shulman HM; Hinterberger W
    Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
    Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
    J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.
    McDonald GB; Hinds MS; Fisher LD; Schoch HG; Wolford JL; Banaji M; Hardin BJ; Shulman HM; Clift RA
    Ann Intern Med; 1993 Feb; 118(4):255-67. PubMed ID: 8420443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation.
    Bunin N; Leahey A; Dunn S
    Transplantation; 1996 Feb; 61(4):664-6. PubMed ID: 8610401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen.
    Brodsky R; Topolsky D; Crilley P; Bulova S; Brodsky I
    Am J Clin Oncol; 1990 Jun; 13(3):221-5. PubMed ID: 2346127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic veno-occlusive disease after bone marrow transplant.
    Carreras E; Grañena A; Rozman C
    Blood Rev; 1993 Mar; 7(1):43-51. PubMed ID: 8467232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
    Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
    Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venocclusive disease of the liver: prospective study of US evaluation.
    Hommeyer SC; Teefey SA; Jacobson AF; Higano CS; Bianco JA; Colacurcio CJ; McDonald GB
    Radiology; 1992 Sep; 184(3):683-6. PubMed ID: 1509050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation.
    Matute-Bello G; McDonald GD; Hinds MS; Schoch HG; Crawford SW
    Bone Marrow Transplant; 1998 Jun; 21(11):1125-30. PubMed ID: 9645575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation.
    Südhoff T; Heins M; Söhngen D; Lenz V; Wehmeier A; Aul C; Meckenstock G; Schneider W; Reinauer H; Heyll A
    Eur J Haematol; 1998 Feb; 60(2):106-11. PubMed ID: 9508351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
    Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
    Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.